Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS
This is an excerpt from a member-only article. To read the article in its entirety, please login or subscribe.

Calls for industry transparency increasing

Transparency will be a huge frontier for pharmaceutical companies during the next three to four years. John T. Bentivoglio, JD, cochair of King & Spaulding’s FDA/Healthcare Practice in Washington, DC, says he can’t overemphasize the importance of transparency.